News
AA owners over the years. The company has been through a succession of owners during the last 25 years. In 1999, it was bought by Centrica, the owner of British Gas, for £1.1bn.
AA games have production values that are comparable with AAA blockbusters — you know: full voice acting, cinematic cutscenes, fancy 3D graphics — and occupy similar genres, but tend to have a ...
The MCLA has released its Division I all-tournament team from the 2025 MCLA National Championships.Division I All-Tournament TeamA – Brooks Baro, Georgia TechA ...
Home Sports MCLA Rewind – Huskies take two on the road. Sports. MCLA Rewind – Huskies take two on the road. By Jake Loomis. April 10, 2025. 0. 74. Share. Facebook. Twitter. The UConn club men’s ...
The UConn club lacrosse team, following their losses down south, shifted their focus towards the Liberty Flames, who are a powerhouse in D1 MCLA. Led by Caleb Hammet, a former D1 transfer from UMass ...
3mon
Sentinel & Enterprise on MSNJustice Dept. reports 'unlawful and unconstitutional' conduct at Worcester PD - MSNMar. 8—FITCHBURG — It's been a long time coming.Fourth-seeded Fitchburg State captured its first MASCAC tournament title since 2018 on Saturday, ending the unlikely run of No 8 MCLA with a 3-1 ...
A month ago, it would have been hard to imagine the Fitchburg State ice hockey team playing in the MASCAC championship game. Its opponent on Saturday has an even more unbelievable road to the final.
Background: MCLA-129 is a common light chain, Biclonics, bispecific antibody targeting EGFR and c-MET with enhanced antibody-dependent cellular cytotoxicity. Here we describe the ongoing ...
Background: MCLA-145, a human common light chain bispecific antibody targeting CD137 and the PD-1/PD-L1 axis, is designed to enhance both antigen-mediated T cell activation via CD137 costimulation, ...
Aplastic anemia prognosis in adults depends on many factors, like age and overall health, severity of AA, and response to treatment. Advances in treatment are improving people's outlooks.
MCLA-129 in combination with chemotherapy in 2L+ EGFRm NSCLC planned to initiate 1Q24. UTRECHT, The Netherlands and CAMBRIDGE, Mass., Dec. 02, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results